Warren Buffett provided commentary on investment risk, using Alnylam Pharmaceuticals as a subject of stock analysis.
2 reports, 2 independent
Updated Oct 29
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Warren Buffett provided commentary on investment risk, using Alnylam Pharmaceuticals as a subject of stock analysis.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alnylam Pharmaceuticals
biopharmaceutical company
-
Warren Buffett
American investor, entrepreneur and businessman
Related events
- Warren Buffett's investment approach is cited in relation to Mirae Asset.
- Warren Buffett's investment advice is related to market behavior studies conducted by Dimensional Fund Advisors.
- Warren Buffett concentrates his investments within the Berkshire Hathaway conglomerate.
- Suze Orman referenced the financial strategies of Warren Buffett.
- Warren Buffett published an opinion article in the New York Times.
Coverage
Newest first; wire copies grouped- investorplace.com
- Simply Wall St.Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Too Much Debt? Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatil